Clinical trial

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

NCT02463994

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-10-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2015-10-01Date precision: month

Registry last updated2019-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

MPDL3280ADRUG

Hypofractionated RadiotherapyRADIATION

Sponsors & collaborators

University of Michigan Rogel Cancer Centerlead sponsor

University of Washingtoncollaborator

Mapped research locations

SeattleWashington, United States1 Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02463994 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.